DNA Extraction, Isolation, Purification Market Worth $6.10 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
04 oct. 2023 09h25 HE
|
The Insight Partners
Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The method through which the DNA is purified is DNA extraction, by using physical and/or chemical methods from proteins, cell membranes, and other...
Poultry Diagnostics Market worth $792.70 Million by 2030 - Exclusive Report by The Insight Partners
22 sept. 2023 09h06 HE
|
The Insight Partners
Pune, India, Sept. 22, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Poultry Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth...
Achiko AG Production and Sales Update
21 déc. 2022 07h42 HE
|
Achiko AG
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests.Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match...
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders Adopt All Proposals
20 déc. 2022 15h03 HE
|
Achiko AG
ZURICH, Switzerland, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) held its Annual General Meeting today at 10:00 CET in Zurich....
Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test
06 déc. 2022 07h03 HE
|
Lucira Health Inc.
Lucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and...
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
17 nov. 2022 07h03 HE
|
Lucira Health Inc.
Digital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costsLucira...
Achiko AG Announces Corporate Update Webcast
16 nov. 2022 10h38 HE
|
Achiko AG
ZURICH, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare technology company that is developing new...
Achiko AG Commences Commercial Deliveries in Indonesia
14 nov. 2022 07h30 HE
|
Achiko AG
ZURICH, Switzerland, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud to...
Achiko AG Production and Company Update
02 nov. 2022 07h34 HE
|
Achiko AG
Completing Production Pilot for Generation 2 of AptameX™ as a Precursor to Mass Commercial ProductionExpect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of...
Achiko AG Appoints New Chief Financial Officer
07 oct. 2022 07h30 HE
|
Achiko AG
ZURICH, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare...